Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 4
Understanding Treatment Outcomes and Immunologic Mechanisms in ALtuviiio Immune Tolerance Induction
The goal of this clinical trial is to learn how well Altuviiio (efanesoctacog alpha) works for Immune Tolerance Induction (ITI) while using Hemlibra (emicizuma…
Hemophilia A With Inhibitor
Versiti Blood HealthNCT07158606
Phase 4
Safety of SEVENFACT® for the Treatment of Bleeding Events in Patients With Hemophilia A or B With Inhibitors
Phase IV multi-center, US-centric, open-label, safety study enrolling participants with Hemophilia A or B with inhibitors, 12 years of age and older, who are e…
Hemophilia A With InhibitorHemophilia B With Inhibitor
American Thrombosis and Hemostasis NetworkNCT04647227